Form 4: Carlyle Group Sells Shares in QuidelOrtho Corp Under 10b5-1 Trading Plan
SEC Form 4
The Carlyle Group executed multiple sales of QuidelOrtho Corp (QDEL) common stock between June 12 and June 13, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- The Carlyle Group, through various affiliated entities, sold shares of QuidelOrtho Corp (QDEL) common stock on June 12 and 13, 2024.
- These sales were conducted under a Rule 10b5-1 trading plan adopted on May 12, 2024.
- The transactions involved multiple sales at varying prices, ranging from $36.70 to $41.18 per share.
- A total of 168,597 shares were sold across the reported transactions.
- Following these transactions, Carlyle Partners VI Cayman Holdings, L.P. still holds 12,251,686 shares of QuidelOrtho Corp.
- The Carlyle Group Inc. and its related entities may be deemed to share beneficial ownership of these securities but disclaim such ownership.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing share sales. It doesn't convey any explicit positive or negative sentiment about the company's prospects.
Future Outlook
The document does not contain any specific forward-looking statements regarding QuidelOrtho Corp's future performance or the Carlyle Group's future transactions.
Industry Context
The sale of shares by a major holder like Carlyle Group is a common occurrence, especially when executed under a pre-arranged trading plan. It's important to monitor such transactions to understand potential shifts in ownership and investor sentiment.
Stakeholder Impact
- The share sales could potentially impact the stock price of QuidelOrtho Corp in the short term.
- The transactions may be of interest to current and potential shareholders of QuidelOrtho Corp.
Key Dates
| Date | Description |
|---|---|
| 2023-10-01 | Date of Power of Attorney execution. |
| 2024-05-12 | Date of adoption of Rule 10b5-1 trading plan. |
| 2024-06-12 | Date of first reported transaction. |
| 2024-06-13 | Date of last reported transaction. |
| 2024-06-14 | Date of signatures on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.